Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience

SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are the most common primary site of NETs. Peptide receptor radiation therapy with Lutetium-177-DOTATATE (PRRT) is the standard treatment for grade 1 (G1) or grade 2 (G2) midgut NETs when somatostatin analog therapy fails, but li...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Zenaide Silva, Xavier, Camila Bragança, Gomes, Luciana Beatriz Mendes, de Medeiros, Maria Fernanda Barbosa, de Sousa, Micelange Carvalho, Pereira, Allan Andresson Lima, Marin, José Flávio Gomes, Buchpiguel, Carlos Alberto, Costa, Frederico Perego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526125/
https://www.ncbi.nlm.nih.gov/pubmed/37760475
http://dx.doi.org/10.3390/cancers15184506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526125/
https://www.ncbi.nlm.nih.gov/pubmed/37760475
http://dx.doi.org/10.3390/cancers15184506

Ejemplares similares